GlassScriptPhysician profile
Britton R Crigler
NPI 1952538811
$6,049.21
in general payments reported to CMS, 2019-2025
31 companies · $296 in 2025
The $296 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $201 · 2020: $89.66 · 2021: $334 · 2022: $369 · 2023: $3,018 · 2024: $1,741 · 2025: $296.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Food and Beverage: $1,822 · Travel and Lodging: $733.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Food and Beverage | $1,821.91 |
| Travel and Lodging | $733.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,738.32 | 2023-2024 | Davinci Xi, Da Vinci Surgical System |
| Boston Scientific Corporation | $824.03 | 2022-2023 | |
| Abbvie INC. | $685.75 | 2019-2024 | Orilissa, Lo Loestrin Fe, Liletta |
| Astellas Pharma US INC | $235.78 | 2022-2025 | Veozah, Myrbetriq |
| Mayne Pharma Commercial LLC | $225.92 | 2023-2025 | |
| Minerva Surgical, INC | $199.39 | 2023 | |
| Amgen INC. | $148.38 | 2024-2025 | Evenity, Prolia |
| Mimedx Group, INC. | $125.00 | 2024 | |
| Sumitomo Pharma America, INC. | $120.83 | 2024-2025 | Myfembree |
| Caldera Medical, INC | $89.42 | 2023 | Desara |
| Pfizer INC. | $82.70 | 2020-2024 | |
| Organon LLC | $57.62 | 2023-2024 | Nexplanon |
| Agile Therapeutics, INC. | $53.42 | 2022-2024 | Twirla |
| Biogen, INC. | $48.06 | 2024-2025 | Zurzuvae |
| Optumhealth Care Solutions, LLC | $39.81 | 2024-2025 | Vivify Health Care Team Portal 001, Eitan Medical |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $36.84 | 2025 | Eterna |
| Becton, Dickinson and Company | $33.39 | 2025 | Arista |
| Hologic Sales and Service, LLC | $32.76 | 2022-2023 | Aptima |
| Therapeuticsmd, INC. | $32.52 | 2021 | |
| Duchesnay USA Incorporated | $31.02 | 2019 | |
| Scynexis, INC. | $28.14 | 2022 | |
| Allergan, INC. | $22.10 | 2019 | |
| Myovant Sciences INC. | $21.97 | 2021 | |
| Exeltis, USA INC. | $20.68 | 2022 | |
| Evofem Biosciences, INC. | $20.63 | 2022 | |
| Coopersurgical, INC. | $20.32 | 2024 | Paragard T 380a |
| Bayer Healthcare Pharmaceuticals INC. | $18.18 | 2021 | |
| Baxter Healthcare | $16.65 | 2024 | Perclot |
| Smith+Nephew, INC. | $15.87 | 2025 | Pico 14 |
| Merck Sharp & Dohme LLC | $12.29 | 2021 | |
| Meditrina | $11.42 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Britton Crigler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.